Products for Research Use Only

MS105

CAT: 0804-HY-171830-04Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-171830-04Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MS105 (YX39-105) is an orally active and selective protein tyrosine kinase 6 (PTK6) PROTAC degrader. MS105 recruits VHL E3 ligase via the VHL ligand moiety to promote PTK6 ubiquitination and proteasomal degradation, inhibiting breast cancer cell proliferation, migration, and inducing apoptosis. MS105 is promising for research of breast cancer. (Pink: BRK inhibitor P21d hydrochloride ; Black: linker (HY-W105727) ; Blue: (S, R, S) -AHPC (HY-125845) )[2].
CAS Number
2408339-39-7
Product Name Alternative
YX39-105
UNSPSC
12352005
Target
Apoptosis; PROTACs; Tyrosinase
Related Pathways
Apoptosis; Metabolic Enzyme/Protease; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C([C@H]1N(C([C@@H](NC(CCCCCCCCNC(CN2CCN(C(C3=CC=C(NC4=NC(C5CC5)=CN6C4=NC=C6C7=CNN=C7)C(F)=C3)=O)CC2)=O)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC8=CC=C(C9=C(C)N=CS9)C=C8
Molecular Formula
C56H70FN13O6S
Molecular Weight
1072.30
References & Citations
[1]Martinez C, et al. A PROTAC degrader suppresses oncogenic functions of PTK6, inducing apoptosis of breast cancer cells. Cell Chem Biol. 2025 Feb 20;32 (2) :255-266.e8.|[2]Jian Jin, et al. Protein tyrosine kinase 6 (ptk6) degradation / disruption compounds and methods of use. WO2020010204A1. 2020-01-09.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Chemical Information

(2S,4R)-1-[(2S)-2-[9-[[2-[4-[4-[[6-cyclopropyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-fluorobenzoyl]piperazin-1-yl]acetyl]amino]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
CAS Number2408339-39-7
PubChem CID156701294
IUPAC Name(2S,4R)-1-[(2S)-2-[9-[[2-[4-[4-[[6-cyclopropyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-fluorobenzoyl]piperazin-1-yl]acetyl]amino]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
Molecular FormulaC56H70FN13O6S
Molecular Weight1072.3
XLogP6.5
Topological Polar Surface Area263
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count14
Rotatable Bond Count23
Heavy Atom Count77
Formal Charge0
Complexity1970
SMILES
CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCNC(=O)CN4CCN(CC4)C(=O)C5=CC(=C(C=C5)NC6=NC(=CN7C6=NC=C7C8=CNN=C8)C9CC9)F)O
InChI
InChI=1S/C56H70FN13O6S/c1-35-49(77-34-61-35)38-14-12-36(13-15-38)27-60-53(74)45-26-41(71)31-70(45)55(76)50(56(2,3)4)66-47(72)11-9-7-5-6-8-10-20-58-48(73)33-67-21-23-68(24-22-67)54(75)39-18-19-43(42(57)25-39)64-51-52-59-30-46(40-28-62-63-29-40)69(52)32-44(65-51)37-16-17-37/h12-15,18-19,25,28-30,32,34,37,41,45,50,71H,5-11,16-17,20-24,26-27,31,33H2,1-4H3,(H,58,73)(H,60,74)(H,62,63)(H,64,65)(H,66,72)/t41-,45+,50-/m1/s1
InChIKey
BVUCYUHIVLTURA-VTRKIVCCSA-N
Chemical Structure
2D Structure
2D structure of (2S,4R)-1-[(2S)-2-[9-[[2-[4-[4-[[6-cyclopropyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-fluorobenzoyl]piperazin-1-yl]acetyl]amino]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
CAS: 2408339-39-7
CID: 156701294
Formula: C56H70FN13O6S
MW: 1072.3
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight1072.3
XLogP36.5
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count14
Rotatable Bond Count23
Exact Mass1071.52767634
Monoisotopic Mass1071.52767634
Topological Polar Surface Area263 Ų
Heavy Atom Count77
Formal Charge0
Complexity1970
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
T207347-01MS105